A. Depriest

发表

Prescribing Opioids for Chronic Noncancer Pain in Primary Care: Risk Assessment

S. Passik, E. Cone, A. Gordon, 2014, Postgraduate medicine.

Risks and Responsibilities in Prescribing Opioids for Chronic Noncancer Pain, Part 2: Best Practices

S. Passik, E. Cone, A. Gordon, 2014, Postgraduate medicine.

Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use.

R. Heltsley, E. Cone, Y. Caplan, 2010, Journal of analytical toxicology.

Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.

R. Heltsley, E. Cone, Y. Caplan, 2013, Journal of analytical toxicology.

Prescription opioids. III. Disposition of oxycodone in oral fluid and blood following controlled single-dose administration.

R. Heltsley, E. Cone, D. Black, 2015, Journal of analytical toxicology.

Urine drug testing of chronic pain patients. IV. prevalence of gabapentin and pregabalin.

R. Heltsley, E. Cone, Y. Caplan, 2011, Journal of analytical toxicology.

Metabolism and Disposition of Prescription Opioids: A Review.

E. Cone, A. Depriest, B. Puet, 2015, Forensic science review.

Prevalence of heroin markers in urine for pain management patients.

R. Heltsley, E. Cone, Y. Caplan, 2014, Forensic science international.

Immunoassay in healthcare testing applications.

T. Robert, D. Black, A. Depriest, 2015, Journal of opioid management.

Drug Testing in Pain Management

A. Depriest, Anne Depriest, 2020, Principles of Forensic Toxicology.

Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens.

R. Heltsley, E. Cone, Y. Caplan, 2012, Journal of analytical toxicology.

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration.

R. Heltsley, E. Cone, D. Black, 2015, Journal of analytical toxicology.

Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.

R. Heltsley, E. Cone, Y. Caplan, 2011, Journal of analytical toxicology.

Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration.

R. Heltsley, E. Cone, D. Black, 2016, Journal of analytical toxicology.

Pseudoephedrine and False‐Positive Immunoassay Urine Drug Tests for Amphetamine

D. Black, A. Depriest, P. Doering, 2013, Pharmacotherapy.

Determining zolpidem compliance: urinary metabolite detection and prevalence in chronic pain patients.

R. Heltsley, E. Cone, Y. Caplan, 2014, Journal of analytical toxicology.

Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence

A. Depriest, Katie L Miller, Anne Depriest, 2014, Pain and Therapy.

Prevalence of synthetic cannabinoids in U.S. athletes: initial findings.

R. Heltsley, T. Robert, M. Shelby, 2012, Journal of analytical toxicology.